Carol Reynolds

11.9k total citations · 2 hit papers
121 papers, 8.8k citations indexed

About

Carol Reynolds is a scholar working on Pathology and Forensic Medicine, Cancer Research and Oncology. According to data from OpenAlex, Carol Reynolds has authored 121 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Pathology and Forensic Medicine, 55 papers in Cancer Research and 49 papers in Oncology. Recurrent topics in Carol Reynolds's work include Breast Lesions and Carcinomas (55 papers), Breast Cancer Treatment Studies (52 papers) and Cancer and Skin Lesions (29 papers). Carol Reynolds is often cited by papers focused on Breast Lesions and Carcinomas (55 papers), Breast Cancer Treatment Studies (52 papers) and Cancer and Skin Lesions (29 papers). Carol Reynolds collaborates with scholars based in United States, Spain and Vietnam. Carol Reynolds's co-authors include Susan G. Orel, Katrina N. Glazebrook, Wilma L. Lingle, Daniel W. Visscher, James N. Ingle, Emile R. Mohler, Martin Keane, Francis H. Gannon, Frederick S. Kaplan and Robert A. Zimmerman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Oncology.

In The Last Decade

Carol Reynolds

120 papers receiving 8.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bone Formation and Inflammation in Cardiac Valves

2001 785 citations Carol Reynolds et al. profile →
Pharmacogenetics of Tamoxifen Biotransformation Is Associated With Clinical Outcomes of Efficacy and Hot Flashes

2005 567 citations Matthew P. Goetz, Vera J. Suman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carol Reynolds United States	51	3.3k	3.2k	3.1k	1.5k	1.5k	121	8.8k
Alain Fourquet France	62	9.5k 2.9×	5.6k 1.8×	5.5k 1.8×	2.6k 1.7×	1.8k 1.2×	374	14.0k
Daniel W. Visscher United States	58	4.3k 1.3×	3.2k 1.0×	4.7k 1.5×	1.4k 0.9×	1.5k 1.0×	228	11.0k
M. Spielmann France	47	3.1k 0.9×	1.3k 0.4×	4.6k 1.5×	1.0k 0.7×	455 0.3×	181	7.2k
David J. Dabbs United States	48	3.2k 1.0×	2.0k 0.6×	3.1k 1.0×	1.2k 0.8×	851 0.6×	205	7.9k
Constance Cirrincione United States	38	4.7k 1.4×	1.6k 0.5×	6.8k 2.2×	750 0.5×	810 0.5×	81	9.8k
L. Mauriac France	46	5.5k 1.7×	1.2k 0.4×	8.0k 2.6×	587 0.4×	4.0k 2.7×	171	11.5k
Monica Castiglione‐Gertsch Switzerland	50	4.9k 1.5×	1.8k 0.6×	5.6k 1.8×	887 0.6×	2.3k 1.5×	121	8.6k
Mårten Fernö Sweden	52	4.1k 1.2×	1.3k 0.4×	4.9k 1.6×	1.4k 0.9×	1.6k 1.0×	232	10.0k
Nicholas J. Robert United States	44	4.1k 1.2×	926 0.3×	6.7k 2.1×	541 0.4×	2.2k 1.5×	181	10.0k
Daniel J. Booser United States	44	3.5k 1.1×	910 0.3×	5.2k 1.7×	403 0.3×	752 0.5×	105	8.1k

Countries citing papers authored by Carol Reynolds

Since Specialization

Citations

This map shows the geographic impact of Carol Reynolds's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol Reynolds with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol Reynolds more than expected).

Fields of papers citing papers by Carol Reynolds

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol Reynolds. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol Reynolds. The network helps show where Carol Reynolds may publish in the future.

Co-authorship network of co-authors of Carol Reynolds

This figure shows the co-authorship network connecting the top 25 collaborators of Carol Reynolds. A scholar is included among the top collaborators of Carol Reynolds based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol Reynolds. Carol Reynolds is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Suman, Vera J., Malayannan Subramaniam, Xianglin Wu, et al.. (2014). ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer. BMC Cancer. 14(1). 749–749. 54 indexed citations

Harrington, Sean C., S. John Weroha, Carol Reynolds, et al.. (2012). Quantifying insulin receptor isoform expression in FFPE breast tumors. Growth Hormone & IGF Research. 22(3-4). 108–115. 40 indexed citations

Graham, Rondell P., et al.. (2012). Handling of Radioactive Seed Localization Breast Specimens in the Pathology Laboratory. The American Journal of Surgical Pathology. 36(11). 1718–1723. 16 indexed citations

Geiger, Xochiquetzal J., et al.. (2012). Long-Term Follow-up of Lobular Neoplasia (Atypical Lobular Hyperplasia/Lobular Carcinoma In Situ) Diagnosed on Core Needle Biopsy. Annals of Surgical Oncology. 19(10). 3131–3138. 75 indexed citations

Radisky, Derek C., Marta Santisteban, Hal K. Berman, et al.. (2011). p16INK4a Expression and Breast Cancer Risk in Women with Atypical Hyperplasia. Cancer Prevention Research. 4(12). 1953–1960. 23 indexed citations

Samayoa, Luis, et al.. (2011). Primary Pulmonary Synovial Sarcoma Presenting as a Breast Mass. The Breast Journal. 17(4). 418–419. 3 indexed citations

Shah, Sejal, Rhett P. Ketterling, Matthew P. Goetz, et al.. (2009). Impact of American Society of Clinical Oncology/College of American Pathologists guideline recommendations on HER2 interpretation in breast cancer. Human Pathology. 41(1). 103–106. 30 indexed citations

Minot, Douglas M., Benjamin R. Kipp, Reid G. Meyer, et al.. (2009). Automated Cellular Imaging System III for Assessing HER2 Status in Breast Cancer Specimens. American Journal of Clinical Pathology. 132(1). 133–138. 35 indexed citations

Ghosh, Karthik, Kathleen R. Brandt, Thomas A. Sellers, et al.. (2008). Association of Mammographic Density with the Pathology of Subsequent Breast Cancer among Postmenopausal Women. Cancer Epidemiology Biomarkers & Prevention. 17(4). 872–879. 49 indexed citations

10.

Vierkant, Robert A., Lynn C. Hartmann, V. Shane Pankratz, et al.. (2008). Lobular involution: localized phenomenon or field effect?. Breast Cancer Research and Treatment. 117(1). 193–196. 17 indexed citations

11.

Lewis, Jason S., Rhett P. Ketterling, Kevin C. Halling, et al.. (2005). Analysis of Intratumoral Heterogeneity and Amplification Status in Breast Carcinomas With Equivocal (2+) HER-2 Immunostaining. American Journal of Clinical Pathology. 124(2). 273–281. 15 indexed citations

12.

Glazebrook, Katrina N., Marilyn J. Morton, & Carol Reynolds. (2005). Vascular Tumors of the Breast: Mammographic, Sonographic, and MRI Appearances. American Journal of Roentgenology. 184(1). 331–338. 63 indexed citations

13.

Perez, Edith A., Patrick C. Roche, Robert B. Jenkins, et al.. (2002). HER2 Testing in Patients With Breast Cancer: Poor Correlation Between Weak Positivity by Immunohistochemistry and Gene Amplification by Fluorescence In Situ Hybridization. Mayo Clinic Proceedings. 77(2). 148–154. 157 indexed citations

14.

Kudva, Yogish C., et al.. (2002). “Diabetic Mastopathy,” or Sclerosing Lymphocytic Lobulitis, Is Strongly Associated With Type 1 Diabetes. Diabetes Care. 25(1). 121–126. 56 indexed citations

15.

Pruthi, Sandhya, Carol Reynolds, Ruth E. Johnson, & John J. Gisvold. (2001). Tamoxifen in the Management of Pseudoangiomatous Stromal Hyperplasia. The Breast Journal. 7(6). 434–439. 75 indexed citations

16.

Gardner, Heather Perry, Seung I. Ha, Carol Reynolds, & Lewis A. Chodosh. (2000). The caM kinase, Pnck, is spatially and temporally regulated during murine mammary gland development and may identify an epithelial cell subtype involved in breast cancer.. PubMed. 60(19). 5571–7. 20 indexed citations

17.

Orel, Susan G., et al.. (2000). MR Imaging in Patients with Nipple Discharge: Initial Experience. Radiology. 216(1). 248–254. 89 indexed citations

18.

Peterson, Michael E., Delray J. Schultz, Carol Reynolds, & Lawrence J. Solin. (1999). Outcomes in breast cancer patients relative to margin status after treatment with breast-conserving surgery and radiation therapy: the University of Pennsylvania experience. International Journal of Radiation Oncology*Biology*Physics. 43(5). 1029–1035. 108 indexed citations

19.

Abraham, Susan C., David DeNofrio, Evan Loh, et al.. (1998). Desmin myopathy involving cardiac, skeletal, and vascular smooth muscle: Report of a case with immunoelectron microscopy. Human Pathology. 29(8). 876–882. 30 indexed citations

20.

Reynolds, Carol, et al.. (1997). Expression of Prolactin and Its Receptor in Human Breast Carcinoma¹. Endocrinology. 138(12). 5555–5560. 165 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact